Abstract:Objective To explore the effects of nimodipine on early angiogenesis in rat models with craniocerebral injury and its mechanism.Methods Eight of 25 male SD rats were randomly selected as the control group, and the rest rats were used to establish the craniocerebral injury models. Except the one that was unsuccessfully modeled, other rats were divided into model group and nimodipine group, with 8 rats in each group. The nimodipine group was given 1 mg/(kg?d) of nimodipine, while the control group and the model group were given the same amount of normal saline. After 7 days of treatment, the number of vascular endothelial cells, microvessel density (MVD), and hypoxia inducible factor-1α (HIF-Ⅰα) and angiopoietin-2 (Ang-2) levels were measured. The pathological changes of brain tissues and the protein expressions of Akt/ERK pathway-associated molecules were compared among the groups.Results The neurological scores of the model group and nimodipine group were higher relative to those of the control group (P < 0.05), and those of the model group were even higher than those of the nimodipine group (P < 0.05). The number of vascular endothelial cells and MVD in the model group and nimodipine group were higher than those in the control group (P < 0.05), and those in the model group were lower than those in the nimodipine group (P < 0.05). The protein levels of PI3K, pAkt/Akt, and (pERK1/2) / (ERK1/2) in the model group and nimodipine group were higher compared with the control group (P < 0.05), while those of the model group were lower than those of the nimodipine group (P < 0.05).Conclusions Nimodipine promotes early angiogenesis in rat models of craniocerebral injury, and its mechanism may be related to the Akt/ERK pathway.